137 related articles for article (PubMed ID: 26558374)
1. Synthesis, Structural Characterization of a Novel Ferrocene Derivative and Preliminarily Anticancer Activity.
Yong J; Wu X; Liao J; Lu C; Liu X
Med Chem; 2016; 12(5):426-31. PubMed ID: 26558374
[TBL] [Abstract][Full Text] [Related]
2. New Ferrocene Formates Bearing Isoxazole Moieties: Synthesis, Characterization, X-ray Crystallography, and Preliminarily Cytotoxicity against A549, HCT116, and MCF-7 Cell Lines.
Yong J; Lu C; Yang M; Wu X
Curr Pharm Des; 2022; 28(34):2835-2841. PubMed ID: 35996233
[TBL] [Abstract][Full Text] [Related]
3. Potential anticancer agents. I. Synthesis of isoxazole moiety containing quinazoline derivatives and preliminarily in vitro anticancer activity.
Yong JP; Lu CZ; Wu X
Anticancer Agents Med Chem; 2015; 15(1):131-6. PubMed ID: 25142319
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, structural characterization and antitumor activity of novel 2,4-diamino-1,3,5-triazine derivatives.
Brzozowski Z; Saczewski F; Gdaniec M
Eur J Med Chem; 2000 Dec; 35(12):1053-64. PubMed ID: 11248404
[TBL] [Abstract][Full Text] [Related]
5. New Ferrocene Compounds as Selective Cyclooxygenase (COX-2) Inhibitors: Design, Synthesis, Cytotoxicity and Enzyme-inhibitory Activity.
Farzaneh S; Zeinalzadeh E; Daraei B; Shahhosseini S; Zarghi A
Anticancer Agents Med Chem; 2018; 18(2):295-301. PubMed ID: 28971779
[TBL] [Abstract][Full Text] [Related]
6. Anticancer activity of ferrocenylthiosemicarbazones.
Sandra CM; Elena K; Marcos FA; Elena MK; Arturo RR; Teresa RA; Marcos MG
Anticancer Agents Med Chem; 2014 Mar; 14(3):459-65. PubMed ID: 24144199
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of Isoxazole Moiety Containing Thieno[2,3-d]pyrimidine Derivatives and Preliminarily in vitro Anticancer Activity (Part II).
Yong J; Lu C; Wu X
Anticancer Agents Med Chem; 2015; 15(9):1148-55. PubMed ID: 25742095
[TBL] [Abstract][Full Text] [Related]
8. Novel ferrocenylbisphosphonate hybrid compounds: Synthesis, characterization and potent activity against cancer cell lines.
Anusionwu CG; Aderibigbe BA; Adeyemi SA; Ubanako P; Oselusi SO; Choonara YE; Yangkou Mbianda X
Bioorg Med Chem; 2022 Mar; 58():116652. PubMed ID: 35180594
[TBL] [Abstract][Full Text] [Related]
9. Ferrocenylselenoamides: synthesis, characterization and cytotoxic properties.
Gutiérrez-Hernández AI; López-Cortés JG; Ortega-Alfaro MC; Ramírez-Apan MT; Cázares-Marinero Jde J; Toscano RA
J Med Chem; 2012 May; 55(10):4652-63. PubMed ID: 22524555
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and In Vitro Anticancer Activity of 6-Ferrocenylpyrimidin-4(3H)-one Derivatives.
Grabovskiy SA; Muhammadiev RS; Valiullin LR; Raginov IS; Kabal'nova NN
Curr Org Synth; 2019; 16(1):160-164. PubMed ID: 31965930
[TBL] [Abstract][Full Text] [Related]
11. Microwave assisted synthesis of some new fused 1,2,4-triazines bearing thiophene moieties with expected pharmacological activity.
Saad HA; Youssef MM; Mosselhi MA
Molecules; 2011 Jun; 16(6):4937-57. PubMed ID: 21677606
[TBL] [Abstract][Full Text] [Related]
12. Ferrocenes as potential chemotherapeutic drugs: synthesis, cytotoxic activity, reactive oxygen species production and micronucleus assay.
Pérez WI; Soto Y; Ortíz C; Matta J; Meléndez E
Bioorg Med Chem; 2015 Feb; 23(3):471-9. PubMed ID: 25555734
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, crystal structure and anticancer activity of novel derivatives of ethyl 1-(4-oxo-8-aryl-4,6,7,8-tetrahydroimidazo[2,1-c][1,2,4]triazin-3-yl)formate.
Sztanke K; Rzymowska J; Niemczyk M; Dybała I; Kozioł AE
Eur J Med Chem; 2006 Apr; 41(4):539-47. PubMed ID: 16545495
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, spectroscopic investigation, and DFT study of N,N'-disubstituted ferrocene-based thiourea complexes as potent anticancer agents.
Asghar F; Fatima S; Rana S; Badshah A; Butler IS; Tahir MN
Dalton Trans; 2018 Feb; 47(6):1868-1878. PubMed ID: 29337321
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and cytotoxic activity of imidazo[1,2-a]-1,3,5-triazine analogues of 6-mercaptopurine.
Saczewski F; Maruszak M; Bednarski PJ
Arch Pharm (Weinheim); 2008 Feb; 341(2):121-5. PubMed ID: 18186543
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, structure and anticancer activity of novel alkenyl-1,3,5-triazine derivatives.
Saczewski F; Bułakowska A
Eur J Med Chem; 2006 May; 41(5):611-5. PubMed ID: 16540207
[TBL] [Abstract][Full Text] [Related]
17. Heterometallic platinum(II) compounds with β-aminoethylferrocenes: synthesis, electrochemical behaviour and anticancer activity.
Nieto D; González-Vadillo AM; Bruña S; Pastor CJ; Ríos-Luci C; León LG; Padrón JM; Navarro-Ranninger C; Cuadrado I
Dalton Trans; 2012 Jan; 41(2):432-41. PubMed ID: 22025199
[TBL] [Abstract][Full Text] [Related]
18. Solid-phase synthesis and antitumor evaluation of 2,4-diamino-6-aryl-1,3,5-triazines.
Hu Z; Ma T; Chen Z; Ye Z; Zhang G; Lou Y; Yu Y
J Comb Chem; 2009 Mar; 11(2):267-73. PubMed ID: 19125569
[TBL] [Abstract][Full Text] [Related]
19. Acylated mono-, bis- and tris- cinchona-based amines containing ferrocene or organic residues: synthesis, structure and in vitro antitumor activity on selected human cancer cell lines.
Károlyi BI; Bösze S; Orbán E; Sohár P; Drahos L; Gál E; Csámpai A
Molecules; 2012 Feb; 17(3):2316-29. PubMed ID: 22367026
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and in vitro anticancer evaluation of some 4,6-diamino-1,3,5-triazine-2-carbohydrazides as Rad6 ubiquitin conjugating enzyme inhibitors.
Kothayer H; Spencer SM; Tripathi K; Westwell AD; Palle K
Bioorg Med Chem Lett; 2016 Apr; 26(8):2030-4. PubMed ID: 26965855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
